Avalon Investment & Advisory’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,197
Closed -$255K 343
2021
Q2
$255K Sell
1,197
-530
-31% -$112K 0.01% 330
2021
Q1
$353K Sell
1,727
-95,805
-98% -$18.9M 0.01% 305
2020
Q4
$17.8M Sell
97,532
-1,213
-1% -$206K 0.36% 84
2020
Q3
$16.5M Buy
98,745
+29,207
+42% +$4.92M 0.37% 85
2020
Q2
$11.3M Sell
69,538
-6,464
-9% -$1.16M 0.26% 113
2020
Q1
$13.1M Buy
76,002
+74,597
+5,309% +$14.8M 0.34% 95
2019
Q4
$282K Buy
1,405
+123
+10% +$25.2K 0.01% 295
2019
Q3
$271K Buy
1,282
+125
+11% +$26.1K 0.01% 282
2019
Q2
$225K Sell
1,157
-839
-42% -$155K 0.01% 297
2019
Q1
$329K Buy
+1,996
New +$353K 0.01% 289
2018
Q3
Sell
-1,418
Closed -$232K 357
2018
Q2
$232K Buy
+1,418
New +$232K 0.01% 329

Other funds holding CME

Avalon Investment & Advisory's CME Position: Q3 2021 in Review

Avalon Investment & Advisory sold out of CME Group (CME) in Q3 2021, closing a stake of 1,197 shares — an estimated $255K sold.

Avalon Investment & Advisory first reported a position in CME in Q2 2018 and held it in 11 quarters. The position peaked at $17.8M in Q4 2020. 1,054 funds tracked by Wall St. Rank hold CME as of Q3 2021.

  • Avalon Investment & Advisory reported no remaining CME Group position as of Q3 2021 after selling out during the quarter.
  • Avalon Investment & Advisory sold 1,197 CME Group shares in Q3 2021, an estimated $255K.
  • Avalon Investment & Advisory first reported a position in CME Group in Q2 2018 and held it in 11 quarters.
  • Avalon Investment & Advisory's CME Group position peaked at $17.8M in Q4 2020.
  • 1,054 funds tracked by Wall St. Rank held CME Group as of Q3 2021.

Based on Avalon Investment & Advisory's 13F filing for Q3 2021, filed 8 Nov 2021.